Change in weight (kg) · patients with schizophrenia
1 finding from 1 review
Health‐related quality of life ‐ not measured · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Leaving the study early · patients with schizophrenia
Paliperidone palmitate showed no clear difference in leaving the study early ‐ any reason Reported by trial author compared with risperidone long‐acting injection (high certainty).
1 finding from 1 review
Leaving the study early ‐ lack of efficacy Reported by trial author · patients with schizophrenia
Paliperidone palmitate probably leads to higher leaving the study early ‐ lack of efficacy Reported by trial author compared with risperidone long‐acting injection (moderate certainty).
1 finding from 1 review
Global state: clinically important change in global state needing additional medication ‐ chlorpromazine · patients with schizophrenia
It is very uncertain whether α‐FLUPENTHIXOL changes global state: clinically important change in global state needing… compared with PLACEBO or β‐FLUPENTHIXOL (very low certainty).
1 finding from 1 review
Mental state and behaviour: clinically important change in general mental state and behaviour · patients with schizophrenia
1 finding from 1 review
Adverse effects/events: incidence of adverse effects/events · patients with schizophrenia
1 finding from 1 review
Hospital admissions · patients with schizophrenia
1 finding from 1 review
General functioning: Poor social functioning ‐ modified Cooper's ratings5,6 · patients with schizophrenia
It is very uncertain whether α‐FLUPENTHIXOL changes general functioning: Poor social functioning ‐ modified Cooper's… compared with PLACEBO or β‐FLUPENTHIXOL (very low certainty).
1 finding from 1 review
Satisfaction with treatment: satisfaction with care for recipients of care or careers · patients with schizophrenia
1 finding from 1 review
Economic: direct costs · patients with schizophrenia
1 finding from 1 review
Compliance: Poor compliance with medication · patients with schizophrenia
It is very uncertain whether ANY FORM OF PSYCHOEDUCATION changes compliance: Not compliant with medication compared with STANDARD CARE (very low certainty).
1 finding from 1 review
Compliance: 2a. With · patients with schizophrenia
It is very uncertain whether ANY FORM OF PSYCHOEDUCATION changes compliance: 2a. With compared with STANDARD CARE (very low certainty).
1 finding from 1 review
Compliance: 2b. With · patients with schizophrenia
ANY FORM OF PSYCHOEDUCATION showed no clear difference in compliance: 2b. With compared with STANDARD CARE (low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
ANY FORM OF PSYCHOEDUCATION may leads to lower relapse: 1. Relapse for any reason ‐ long term compared with STANDARD CARE (low certainty).
1 finding from 1 review
Relapse: 2. Relapse with readmission ‐ long term · patients with schizophrenia
ANY FORM OF PSYCHOEDUCATION may leads to lower relapse: 2. Relapse with readmission ‐ long term compared with STANDARD CARE (low certainty).
1 finding from 1 review
Satisfaction with mental health services: 3. binary outcome ‐ medium term ‐ unsatisfied · patients with schizophrenia
ANY FORM OF PSYCHOEDUCATION may leads to lower satisfaction with mental health services: 3. binary outcome ‐ medium… compared with STANDARD CARE (low certainty).
1 finding from 1 review
Adverse event: Death ‐ long term · patients with schizophrenia
ANY FORM OF PSYCHOEDUCATION showed no clear difference in adverse event: Death ‐ long term compared with STANDARD CARE (low certainty).
1 finding from 1 review
Feasibility and engagement: lost to · patients with acute psychiatric disorders
Day hospital showed no clear difference in feasibility and engagement: lost to compared with inpatient (moderate certainty).
1 finding from 1 review
Extent of hospital care: 1. duration of index admission · patients with acute psychiatric disorders
1 finding from 1 review